Clinical application of acellular dermal matrix covered metal stent in prevention of esophageal stenosis after submucosal dissection

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049460

Enrollment

Unknown

Registered

2021-08-02

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early stage esophageal cancer with lesions larger than 1 / 2 of the circumference

Interventions

Experimental group:Implantation of ADM covered metallic stent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Older than 18 years old; 2. Patients with early esophageal cancer diagnosed and lesion larger than 1 / 2 week of esophageal lumen have indications for endoscopic submucosal dissection (ESD) and agree to endoscopic treatment.

Exclusion criteria

Exclusion criteria: 1. The patient is pregnant; 2. The patient has serious cardiopulmonary disease; 3. The patient took anticoagulants for a long time and could not stop; 4. Other patients who are not suitable for ESD and stent implantation.

Design outcomes

Primary

Measure	Time frame
Safety of stent;Effectiveness of stents;Blood;	—

Countries

China

Contacts

Public ContactGuo Jintao

Shengjing Hospital of China Medical University

guojt@sj-hospital.org+86 18940256654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026